253 related articles for article (PubMed ID: 34198150)
1. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease.
Yao H; Uras G; Zhang P; Xu S; Yin Y; Liu J; Qin S; Li X; Allen S; Bai R; Gong Q; Zhang H; Zhu Z; Xu J
J Med Chem; 2021 Jun; 64(11):7483-7506. PubMed ID: 34024109
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.
Jiang X; Wang Y; Liu C; Xing C; Wang Y; Lyu W; Wang S; Li Q; Chen T; Chen Y; Feng F; Liu W; Sun H
Bioorg Med Chem; 2021 Jan; 30():115940. PubMed ID: 33340937
[TBL] [Abstract][Full Text] [Related]
4. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W
Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367
[TBL] [Abstract][Full Text] [Related]
5. Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.
Zang Y; Liu K; Wang W; Li C; Ma J; Yang J; Chen X; Wang X; Zhang D
Molecules; 2021 Feb; 26(5):. PubMed ID: 33671020
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
Liu Y; Uras G; Onuwaje I; Li W; Yao H; Xu S; Li X; Li X; Phillips J; Allen S; Gong Q; Zhang H; Zhu Z; Liu J; Xu J
Eur J Med Chem; 2022 May; 235():114305. PubMed ID: 35339839
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
[TBL] [Abstract][Full Text] [Related]
10. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease.
Wu X; Ze X; Qin S; Zhang B; Li X; Gong Q; Zhang H; Zhu Z; Xu J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675602
[TBL] [Abstract][Full Text] [Related]
14. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation.
Jiang CS; Ge YX; Cheng ZQ; Song JL; Wang YY; Zhu K; Zhang H
J Comput Aided Mol Des; 2019 May; 33(5):521-530. PubMed ID: 30989573
[TBL] [Abstract][Full Text] [Related]
18. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
[TBL] [Abstract][Full Text] [Related]
19. A molecular approach in drug development for Alzheimer's disease.
Agatonovic-Kustrin S; Kettle C; Morton DW
Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]